TY - JOUR
T1 - Alarming levels of stigma toward generalized dystonia
T2 - A cross-cultural comparison
AU - Gharzai, Laila
AU - Harney, Jennifer
AU - Higgins, Suzanne
AU - High, Robin
AU - Xu, Liyan
AU - Inciarte, Douglas
AU - Ameer, Muhammad Atif
AU - Torres-Russotto, Diego
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020
Y1 - 2020
N2 - Introduction: Although stigma has been linked to poor quality of life, studies examining its prevalence in dystonia are lacking. Our objective was to determine prevalence and predictors of stigma against generalized dystonia in diverse cultural settings. Method: Participants were 273 (65.9% female) patients and visitors approached at primary care clinics from three populations: León, Nicaragua (92 participants); a mostly-Hispanic Clinic in Omaha, NE USA (85 participants); and a mostly-non-Hispanic population in Omaha, Nebraska (96 participants). Participants learned about generalized dystonia, epilepsy and schizophrenia through reading a small vignette and viewing videos, followed by a questionnaire designed to identify stigma. We compared levels of stigma between dystonia and other conditions at different sites and measured variables that could affect them. Results: Prevalence of stigma was high toward dystonia (33.00%), similar to epilepsy and lower than schizophrenia. The results showed a complex relationship between the studied variables and level of stigma, especially with age. Female gender predicted more stigmatizing answers. Country of origin, level of education and self-identification of Hispanic ethnicity did not affect stigma. Learning more personal information about the dystonia patient decreased dystonia, a proof that unjustified preliminary negative judgment was present. Conclusions: Stigma against generalized dystonia was very prevalent across all the communities studied. Demographic and socio-cultural variables had different correlations to level of stigma, underlying the complexity of this problem. The alarming levels of stigma against dystonia justify further studies on how to minimize its impact on our patients.
AB - Introduction: Although stigma has been linked to poor quality of life, studies examining its prevalence in dystonia are lacking. Our objective was to determine prevalence and predictors of stigma against generalized dystonia in diverse cultural settings. Method: Participants were 273 (65.9% female) patients and visitors approached at primary care clinics from three populations: León, Nicaragua (92 participants); a mostly-Hispanic Clinic in Omaha, NE USA (85 participants); and a mostly-non-Hispanic population in Omaha, Nebraska (96 participants). Participants learned about generalized dystonia, epilepsy and schizophrenia through reading a small vignette and viewing videos, followed by a questionnaire designed to identify stigma. We compared levels of stigma between dystonia and other conditions at different sites and measured variables that could affect them. Results: Prevalence of stigma was high toward dystonia (33.00%), similar to epilepsy and lower than schizophrenia. The results showed a complex relationship between the studied variables and level of stigma, especially with age. Female gender predicted more stigmatizing answers. Country of origin, level of education and self-identification of Hispanic ethnicity did not affect stigma. Learning more personal information about the dystonia patient decreased dystonia, a proof that unjustified preliminary negative judgment was present. Conclusions: Stigma against generalized dystonia was very prevalent across all the communities studied. Demographic and socio-cultural variables had different correlations to level of stigma, underlying the complexity of this problem. The alarming levels of stigma against dystonia justify further studies on how to minimize its impact on our patients.
KW - Cross-cultural comparison
KW - Discrimination
KW - Dystonia
KW - Epilepsy
KW - Prejudice
KW - Schizophrenia
KW - Stigma
UR - http://www.scopus.com/inward/record.url?scp=85109172432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109172432&partnerID=8YFLogxK
U2 - 10.1016/j.prdoa.2020.100059
DO - 10.1016/j.prdoa.2020.100059
M3 - Article
C2 - 34316641
AN - SCOPUS:85109172432
SN - 2590-1125
VL - 3
JO - Clinical Parkinsonism and Related Disorders
JF - Clinical Parkinsonism and Related Disorders
M1 - 100059
ER -